Trials / Completed
CompletedNCT00680108
A Study to Determine the Safety and Tolerability of Escalating Doses of INS365 Ophthalmic Solution
A Double-Masked, Randomized, Placebo-Controlled, Rising-Dose Study of Multiple Ocular Instillations of INS365 Ophthalmic Solution in Patients With Mild to Moderate Dry Eye Disease.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 62 (estimated)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- —
- Age
- —
- Healthy volunteers
- —
Summary
The purpose of this study is to evaluate the safety and tolerability of INS365 Ophthalmic Solution when applied topically as eyedrops in patients with mild to moderate dry eye disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | diquafosol tetrasodium (INS365) ophthalmic solution |
Timeline
- Start date
- 1999-09-01
- Primary completion
- 2000-05-01
- Completion
- 2000-05-01
- First posted
- 2008-05-19
- Last updated
- 2015-08-27
Source: ClinicalTrials.gov record NCT00680108. Inclusion in this directory is not an endorsement.